IBJNews

VC headwinds continue for life sciences firms

Back to TopCommentsE-mailPrintBookmark and Share

Indiana life sciences companies trying to raise venture capital continue to do so with a national wind in their faces, according to third-quarter venture capital data.

Venture capital raised by biotech, health care services and medical technology firms through the first nine months of the year totaled nearly $4.9 billion, essentially flat compared with the same period in 2012, according to the MoneyTree Report released last week by PricewaterhouseCoopers and the National Venture Capital Association, based on data from Thomson Reuters.

But that amount of fundraising is off 20 percent from 2011, and 30 percent from 2008 levels, according to the MoneyTree report.

The number of life sciences deals fell 7 percent to 566 nationally, off nearly 25 percent from 2008 levels.

Health care and life sciences firms have been stymied by rising demands from the U.S. Food and Drug Administration, as well as poorer financial prospects as the federal Medicare program and private health insurers get toughter on reimbursement policies. Also, health care technologies take longer to develop than information technology, which has been the hottest area for venture capital.

“The health care sector is what we would call comparatively capital inefficient. It takes more time to get to an exit, whether that be a sale or an IPO, than it does a technology company,” said Brian Williams, a former Indiana venture capitalist who is now a health care consultant for PricewaterhouseCoopers. “That just creates an additional burden on entrepreneurs who want to be effective in [health care]. The ideas have to be that much better to win.”

No Indiana life sciences companies raised venture capital during the third quarter, according to the MoneyTree report.

That won’t help Indiana’s standing against its peers in the Midwest. Through the first half of the year, Indiana ranked 6th out of 11 Midwest states in life sciences venture capital raised and 7th in number of deals, according to data compiled by Ohio-based BioEnterprise, a life sciences business development group.

Five Hoosier life sciences companies attracted $11.7 million in capital from January through June, according to the semi-annual BioEnterprise report.

Those trends have contributed to a dry spell of venture capital in Indiana. Firms here have raised a total of $20.9 million through the first nine months of the year, down two-thirds from this point last year.

In fact, Indiana’s entrepreneurial firms haven’t been close to this low level of fundraising since 2003, when they had raised $24 million through the first nine months.

The only firm to raise venture capital in the third quarter, according to the MoneyTree report, was West Lafayette-based Spensa Technologies Inc., which is making software for the agriculture industry.

Williams acknowledged that Indiana’s software industry is in a transition between the initial public offering or sale of such previous stars as Angie’s List, ExactTarget and Compendium Blogware, and the reinvestment of those earnings into new ventures.

When it comes to life sciences companies, however, Williams, a former aide to former Democratic Gov. Evan Bayh, pinned the blame on Indiana’s public sector. He said cuts in funding by the state government has harmed the competitiveness of Indiana’s universities. Williams’ wife is a lobbyist for Purdue University.

Williams also said Indiana’s failure to fully embrace health care reform is not an encouraging signal to entrepreneurs.

“You’re continuing to tell me as an entrepreneur that I need to bear the economic risk of the health of my employees,” Williams said.

ADVERTISEMENT

  • Free Market realities
    Proving once again that life sciences is unlike other industries. Admittedly this sector is subject to regulatory rigour unlike many other businesses; however, the bluster of the free mouseketeers is apparently tempered if guaranteed investment or profits aren't forthcoming from government. This doesn't have to be adversarial. Just a recognition that much of the advancement is complicated, needs and deserves public as well as private support, so we can all benefit.

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. If I were a developer I would be looking at the Fountain Square and Fletcher Place neighborhoods instead of Broad Ripple. I would avoid the dysfunctional BRVA with all of their headaches. It's like deciding between a Blackberry or an iPhone 5s smartphone. BR is greatly in need of updates. It has become stale and outdated. Whereas Fountain Square, Fletcher Place and Mass Ave have become the "new" Broad Ripples. Every time I see people on the strip in BR on the weekend I want to ask them, "How is it you are not familiar with Fountain Square or Mass Ave? You have choices and you choose BR?" Long vacant storefronts like the old Scholar's Inn Bake House and ZA, both on prominent corners, hurt the village's image. Many business on the strip could use updated facades. Cigarette butt covered sidewalks and graffiti covered walls don't help either. The whole strip just looks like it needs to be power washed. I know there is more to the BRV than the 700-1100 blocks of Broad Ripple Ave, but that is what people see when they think of BR. It will always be a nice place live, but is quickly becoming a not-so-nice place to visit.

  2. I sure hope so and would gladly join a law suit against them. They flat out rob people and their little punk scam artist telephone losers actually enjoy it. I would love to run into one of them some day!!

  3. Biggest scam ever!! Took 307 out of my bank ac count. Never received a single call! They prey on new small business and flat out rob them! Do not sign up with these thieves. I filed a complaint with the ftc. I suggest doing the same ic they robbed you too.

  4. Woohoo! We're #200!!! Absolutely disgusting. Bring on the congestion. Indianapolis NEEDS it.

  5. So Westfield invested about $30M in developing Grand Park and attendance to date is good enough that local hotel can't meet the demand. Carmel invested $180M in the Palladium - which generates zero hotel demand for its casino acts. Which Mayor made the better decision?

ADVERTISEMENT